Skip to main content
logo
Corline Biomedical AB (STO:CLBIO)
Sweden flag Sweden · Delayed Price · Currency is SEK
14.25
+0.05 (0.35%)
Sep 22, 2026, 1:48 PM CET

Corline Biomedical AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
12.397.659.7835.5223.557.06
Revenue Growth
54.37%-21.73%-72.48%50.82%233.48%91.07%
Gross Profit
10.985.295.9428.3813.69-1.03
Operating Income
-12.42-14.79-13.59-2.22.33-6.91
Net Income
-12.32-14.71-23.19-1.812.33-6.92
Earnings Per Share
-0.48-0.59-1.06-0.080.11-0.34
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
32.9920.5617.6717.0126.2141.64
Total Debt
4.923.832.01---
Net Cash (Debt)
28.0816.7215.6617.0126.2141.64
Net Cash Growth
237.36%6.80%-7.96%-35.09%-37.05%363.07%
Net Cash Per Share
1.100.680.720.791.192.04

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-14.44-17.69-8.640.89-6.45-4.84
Capital Expenditures
-0.38-0.05--0.13-0.15-0.14
Free Cash Flow
-14.82-17.74-8.640.75-6.61-4.98
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
88.63%69.15%60.81%79.90%58.11%-14.59%
Operating Margin
-100.24%-193.24%-139.01%-6.20%9.89%-97.83%
Pretax Margin
-99.48%-192.31%-237.28%-5.09%9.89%-98.02%
Profit Margin
-99.48%-192.31%-237.28%-5.09%9.89%-98.02%
FCF Margin
-119.64%-231.81%-88.38%2.12%-28.05%-70.45%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----85.08-
Forward PE
-38.9213.413.90108.00108.00
P/FCF Ratio
---424.69--
PS Ratio
30.0646.0719.309.028.4144.43